Skip to search formSkip to main contentSkip to account menu

Biolimus A9

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

umirolimus

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Impact of current smoking on 2-year clinical outcomes between durable-polymer-coated stents and biodegradable-polymer-coated stents in acute myocardial infarction after successful percutaneous…
Objective Data concerning the effect of current smoking on solely new-generation drug-eluting stents (DES) are limited. We… 
2017
2017
Biolimus-eluting versus everolimus-eluting stents in coronary artery disease: a pooled analysis from the NEXT (NOBORI biolimus-eluting versus XIENCE/PROMUS everolimus-eluting stent) and COMPARE II…
AIMS This study sought to investigate the safety and efficacy of a biolimus-eluting stent with biodegradable polymer (BP-BES… 
2014
2014
Vascular response to drug-eluting stent with biodegradable vs. durable polymer. Optical coherence tomography substudy of the NEXT.
BACKGROUND The aim of the present study was to compare vascular healing response between everolimus-eluting stent (EES) and… 
2014
2014
Comparison of Biolimus A9–Eluting (Nobori) and Everolimus-Eluting (Promus Element) Stents in Patients With De Novo Native Long Coronary Artery Lesions: A Randomized Long Drug-Eluting Stent V Trial
Background—Procedural and clinical outcomes still remain unfavorable for patients with long coronary lesions who undergo… 
2014
2014
Two-year outcome of a randomized trial comparing second-generation drug-eluting stents using biodegradable or durable polymer.
Recent network meta-analyses have raised concerns about the safety of biodegradable polymer drug-eluting stents (BP-DES) compared… 
2014
2014
Incidence and Clinical Impact of Stent Fracture After the Nobori Biolimus‐Eluting Stent Implantation
Background Stent fracture (SF) after drug‐eluting stent implantation has become an important concern. The aim of this study was… 
2014
2014
Randomised comparison of strut coverage between Nobori biolimus-eluting and sirolimus-eluting stents: an optical coherence tomography analysis.
AIMS The aims of this study were to compare strut tissue coverage at six-month follow-up after Nobori biolimus-eluting stent (N… 
Highly Cited
2012
Highly Cited
2012
Randomized comparison of the nobori biolimus A9‐eluting stent with the sirolimus‐eluting stent in patients with stenosis in native coronary arteries
Objectives: The aim of this randomized‐controlled trial is to compare Biolimus A9‐eluting stent (Nobori) to sirolimus eluting… 
Highly Cited
2008
Highly Cited
2008
The pharmacokinetics of Biolimus A9 after elution from the Nobori stent in patients with coronary artery disease: The NOBORI PK study
The aim of this study was to assess the pharmacokinetics and tolerability of Biolimus A9 eluted from Nobori coronary stents. 
Highly Cited
2007
Highly Cited
2007
Randomised comparison of Nobori, biolimus A9-eluting coronary stent with a Taxus(R), paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the Nobori 1 trial.
BACKGROUND We studied the Nobori coronary stent coated with a bioabsorbable polymer and the anti-proliferative agent Biolimus A9… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)